Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

Werewolf Therapeutics explores strategic alternatives amid push for PREDATOR™ platform monetization

Werewolf Therapeutics (NASDAQ:HOWL), an innovative biopharmaceutical company developing "inducible" cytokines to treat cancer, today announced it has initiated a formal process to explore strategic alternatives.

Leia mais: Werewolf Therapeutics explores strategic alternatives amid push for PREDATOR™ platform monetization
Grafa

Satellos Bioscience reports 2025 financial results, announces $57.2M equity financing

Satellos Bioscience (NASDAQ:MSLE), a biotechnology company focused on developing small-molecule therapies that modulate muscle stem cell regeneration, reported its full-year 2025 financial results and provided updates on recent corporate and clinical milestones.

Leia mais: Satellos Bioscience reports 2025 financial results, announces $57.2M equity financing
Grafa

Autolus reports strong first year for AUCATZYL as CAR-T commercialization scales

Autolus Therapeutics (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: Autolus reports strong first year for AUCATZYL as CAR-T commercialization scales
Grafa
Technology

Super League achieves record revenue and debt-free status following 2025 turnaround

Super League (NASDAQ:SLE), a creator and publisher of content experiences and media solutions across the world’s largest immersive platforms, today reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: Super League achieves record revenue and debt-free status following 2025 turnaround
Grafa
Technology

LM Funding America reports revenue growth amid Bitcoin volatility and infrastructure expansion

LM Funding America (NASDAQ:LMFA), a cryptocurrency mining and specialty finance company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: LM Funding America reports revenue growth amid Bitcoin volatility and infrastructure expansion
Grafa

BioXcel Therapeutics advances toward home-use approval for IGALMI following 2025 financial results

BioXcel Therapeutics (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: BioXcel Therapeutics advances toward home-use approval for IGALMI following 2025 financial results
Grafa

Instil Bio shifts to external innovation strategy following discontinuation of lead asset

Instil Bio (NASDAQ:TIL), a clinical-stage biopharmaceutical company, today reported its financial results for the fourth quarter and full year ended December 31, 2025, while outlining a transformative shift in its corporate strategy.

Leia mais: Instil Bio shifts to external innovation strategy following discontinuation of lead asset
Grafa

AstraZeneca’s Tozorakimab delivers milestone Phase III victory in broad COPD population

AstraZeneca (NASDAQ:AZN) today announced positive high-level results from the OBERON and TITANIA Phase III trials, marking a historic milestone in the treatment of chronic obstructive pulmonary disease (COPD).

Leia mais: AstraZeneca’s Tozorakimab delivers milestone Phase III victory in broad COPD population